Globus Medical Stock Filter Stocks by Fundamentals
| GMED Stock | USD 84.49 0.23 0.27% |
Globus Medical fundamentals help investors to digest information that contributes to Globus Medical's financial success or failures. It also enables traders to predict the movement of Globus Stock. The fundamental analysis module provides a way to measure Globus Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Globus Medical stock.
Globus | Shares Owned by Institutions |
Globus Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Globus Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Globus Medical's managers, analysts, and investors.Environmental | Governance | Social |
Globus Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Globus Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Globus Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Globus Medical's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.9 M | Norges Bank | 2024-06-30 | 1.8 M | Champlain Investment Partners, Llc | 2024-09-30 | 1.8 M | Gw&k Investment Management, Llc | 2024-09-30 | 1.8 M | Geneva Capital Management | 2024-09-30 | 1.6 M | Citadel Advisors Llc | 2024-09-30 | 1.6 M | William Blair Investment Management, Llc | 2024-09-30 | 1.6 M | Axa Sa | 2024-06-30 | 1.5 M | Van Berkom And Associates Inc | 2024-09-30 | 1.5 M | Vanguard Group Inc | 2024-09-30 | 10.6 M | Blackrock Inc | 2024-06-30 | 10.3 M |
Globus Fundamentals
| Return On Equity | 0.0222 | ||||
| Return On Asset | 0.0473 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 11.34 B | ||||
| Shares Outstanding | 113.74 M | ||||
| Shares Owned By Insiders | 0.63 % | ||||
| Shares Owned By Institutions | 82.07 % | ||||
| Number Of Shares Shorted | 2.86 M | ||||
| Price To Earning | 73.16 X | ||||
| Price To Book | 2.83 X | ||||
| Price To Sales | 4.64 X | ||||
| Revenue | 1.57 B | ||||
| Gross Profit | 759.12 M | ||||
| EBITDA | 310.13 M | ||||
| Net Income | 122.87 M | ||||
| Cash And Equivalents | 408.01 M | ||||
| Cash Per Share | 4.10 X | ||||
| Total Debt | 520.4 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 6.10 X | ||||
| Book Value Per Share | 29.94 X | ||||
| Cash Flow From Operations | 243.5 M | ||||
| Short Ratio | 4.29 X | ||||
| Earnings Per Share | 0.62 X | ||||
| Price To Earnings To Growth | 2.28 X | ||||
| Target Price | 90.54 | ||||
| Number Of Employees | 5 K | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 11.5 B | ||||
| Total Asset | 5.09 B | ||||
| Retained Earnings | 1.14 B | ||||
| Working Capital | 1.52 B | ||||
| Current Asset | 544.8 M | ||||
| Current Liabilities | 82.69 M | ||||
| Net Asset | 5.09 B |
About Globus Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Globus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Globus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Globus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:Check out Globus Medical Piotroski F Score and Globus Medical Altman Z Score analysis. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 42.231 | Earnings Share 0.62 | Revenue Per Share 18.217 | Quarterly Revenue Growth 0.631 | Return On Assets 0.0473 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.